1-[4-(METHYLSULFONYL)PHENYL]PYRROLIDINE-2-CARBOXYLIC ACID
- $138 - $323
- Product name: 1-[4-(METHYLSULFONYL)PHENYL]PYRROLIDINE-2-CARBOXYLIC ACID
- CAS: 1330783-57-7
- MF: C12H15NO4S
- MW: 269.32
- EINECS:
- MDL Number:MFCD08692421
- Synonyms:1-[4-(METHYLSULFONYL)PHENYL]PYRROLIDINE-2-CARBOXYLIC ACID;Proline, 1-[4-(methylsulfonyl)phenyl]-;1-(4-methanesulfonylphenyl)pyrrolidine-2-carboxylic acid
4 prices
Selected condition:
Brand
- A2B
- Crysdot
- Matrix Scientific
Package
- 250mg
- 500mg
- 1g
- ManufacturerA2B
- Product numberAP18153
- Product description1-(4-methanesulfonylphenyl)pyrrolidine-2-carboxylicacid
- Packaging250mg
- Price$223
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD21015879
- Product description1-(4-(Methylsulfonyl)phenyl)pyrrolidine-2-carboxylicacid 97%
- Packaging1g
- Price$323
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number024368
- Product description1-[4-(Methylsulfonyl)phenyl]pyrrolidine-2-carboxylic acid
- Packaging250mg
- Price$138
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number024368
- Product description1-[4-(Methylsulfonyl)phenyl]pyrrolidine-2-carboxylic acid
- Packaging500mg
- Price$212
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
A2B | AP18153 | 1-(4-methanesulfonylphenyl)pyrrolidine-2-carboxylicacid | 250mg | $223 | 2021-12-16 | Buy |
Crysdot | CD21015879 | 1-(4-(Methylsulfonyl)phenyl)pyrrolidine-2-carboxylicacid 97% | 1g | $323 | 2021-12-16 | Buy |
Matrix Scientific | 024368 | 1-[4-(Methylsulfonyl)phenyl]pyrrolidine-2-carboxylic acid | 250mg | $138 | 2021-12-16 | Buy |
Matrix Scientific | 024368 | 1-[4-(Methylsulfonyl)phenyl]pyrrolidine-2-carboxylic acid | 500mg | $212 | 2021-12-16 | Buy |
Properties
Melting point :167-170°C
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||
Precautionary statements: |
|